Midterm Outcomes After Osteochondral Allograft Transplantation in the Knee Using High-Chondrocyte Viability Grafts.

James L Cook,Kylee Rucinski,Emily V Leary,Jinpu Li,Cory R Crecelius,Clayton W Nuelle,James P Stannard
{"title":"Midterm Outcomes After Osteochondral Allograft Transplantation in the Knee Using High-Chondrocyte Viability Grafts.","authors":"James L Cook,Kylee Rucinski,Emily V Leary,Jinpu Li,Cory R Crecelius,Clayton W Nuelle,James P Stannard","doi":"10.1177/03635465241285457","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nOsteochondral allograft transplantation (OCAT) has become a standard-of-care treatment option for patients with large symptomatic articular defects. Recent advances in allograft science and OCAT protocols have been reported to result in consistently robust outcomes after OCAT in the knee. However, only short-term comparisons have been reported, and analyses are lacking for treatment failure risk factors that account for confounding variables.\r\n\r\nHYPOTHESIS\r\nMidterm functional graft survival rate would exceed 80% for all OCATs combined, with consideration of risk factors for lower survivorship including older patient age, higher body mass index (BMI), tibiofemoral bipolar OCAT, and nonadherence to prescribed postoperative rehabilitation protocols.\r\n\r\nSTUDY DESIGN\r\nCase series; Level of evidence, 4.\r\n\r\nMETHODS\r\nPatients with outcome data available at ≥5 years after primary OCAT using high chondrocyte-viability (HCV) osteochondral allografts were analyzed according to 2 clinically relevant definitions: (1) initial treatment failure, defined by revision or arthroplasty surgery performed for the primary OCAT at any time point during the study period; and (2) functional graft failure, defined by documented conversion to arthroplasty after primary or revision OCAT at any time point during the study period. Analyses were used to assess outcomes for each definition, separately for age group, sex, obesity status, tobacco use, type of OCAT surgery, osteotomy status, concurrent ligament surgery status, and adherence to postoperative protocols. Kaplan-Meier analyses were used to assess differences in survival rates, and Cox proportional hazards models were used to assess risk factors and multivariable relationships with survival. Patient-reported outcome measures for pain, function, mobility, and satisfaction were also analyzed.\r\n\r\nRESULTS\r\nAnalysis included 137 primary knee OCATs performed in 134 patients with a mean follow-up of 66 months (59 female, 75 male; mean age, 37.8 years; mean BMI, 28.5). The midterm (5- to 8-year) functional graft survival rate for patients undergoing primary OCAT in the knee using HCV grafts was 82% for all cases combined, ranging from 69% for tibiofemoral bipolar HCV OCATs to 89% for patellofemoral bipolar, 94% for multisurface unipolar, and 97% for single-surface unipolar. Initial treatment failure rates (revision or arthroplasty after primary OCAT) and OCAT nonsurvival rates (arthroplasty after primary or revision OCAT) were greater for older patient age, concurrent ligament reconstruction, tibiofemoral bipolar OCAT, and nonadherence to the prescribed postoperative rehabilitation protocols. When adjusted for patients' age, BMI, and tobacco use status, different surgery types did not demonstrate an increased risk for failure, while concurrent ligament reconstruction and nonadherence did. Patients who experienced functional graft survival after primary OCAT reported significantly greater improvements in PROMIS Physical Function and Mobility (Patient-Reported Outcomes Measurement Information System), International Knee Documentation Committee questionnaire, and Single Assessment Numeric Evaluation scores such that they were significantly higher at final follow-up as compared with patients who required arthroplasty. Patient-reported improvements in pain, function, and mobility exceeded minimal clinically important differences for ≥5 years after primary OCAT. When asked if they were satisfied with primary OCAT surgery, 76.2% of patients were very satisfied or satisfied with their results, while 8.5% were neutral and 15.4% were unsatisfied or very unsatisfied.\r\n\r\nCONCLUSION\r\nWith use of HCV osteochondral allografts, midterm (5- to 8-year) functional graft survival rates for patients undergoing primary OCAT in the knee were notably higher than previously reported midterm rates for traditional OCATs. When adjusted for patient characteristics, risk factors for nonsurvival included concurrent ligament reconstruction for knee instability and nonadherence to the prescribed postoperative rehabilitation protocols. Patients who experienced functional graft survival for ≥5 years after primary OCAT reported statistically significant and clinically meaningful improvements in pain, function, and mobility.","PeriodicalId":517411,"journal":{"name":"The American Journal of Sports Medicine","volume":"4 1","pages":"3635465241285457"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American Journal of Sports Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/03635465241285457","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Osteochondral allograft transplantation (OCAT) has become a standard-of-care treatment option for patients with large symptomatic articular defects. Recent advances in allograft science and OCAT protocols have been reported to result in consistently robust outcomes after OCAT in the knee. However, only short-term comparisons have been reported, and analyses are lacking for treatment failure risk factors that account for confounding variables. HYPOTHESIS Midterm functional graft survival rate would exceed 80% for all OCATs combined, with consideration of risk factors for lower survivorship including older patient age, higher body mass index (BMI), tibiofemoral bipolar OCAT, and nonadherence to prescribed postoperative rehabilitation protocols. STUDY DESIGN Case series; Level of evidence, 4. METHODS Patients with outcome data available at ≥5 years after primary OCAT using high chondrocyte-viability (HCV) osteochondral allografts were analyzed according to 2 clinically relevant definitions: (1) initial treatment failure, defined by revision or arthroplasty surgery performed for the primary OCAT at any time point during the study period; and (2) functional graft failure, defined by documented conversion to arthroplasty after primary or revision OCAT at any time point during the study period. Analyses were used to assess outcomes for each definition, separately for age group, sex, obesity status, tobacco use, type of OCAT surgery, osteotomy status, concurrent ligament surgery status, and adherence to postoperative protocols. Kaplan-Meier analyses were used to assess differences in survival rates, and Cox proportional hazards models were used to assess risk factors and multivariable relationships with survival. Patient-reported outcome measures for pain, function, mobility, and satisfaction were also analyzed. RESULTS Analysis included 137 primary knee OCATs performed in 134 patients with a mean follow-up of 66 months (59 female, 75 male; mean age, 37.8 years; mean BMI, 28.5). The midterm (5- to 8-year) functional graft survival rate for patients undergoing primary OCAT in the knee using HCV grafts was 82% for all cases combined, ranging from 69% for tibiofemoral bipolar HCV OCATs to 89% for patellofemoral bipolar, 94% for multisurface unipolar, and 97% for single-surface unipolar. Initial treatment failure rates (revision or arthroplasty after primary OCAT) and OCAT nonsurvival rates (arthroplasty after primary or revision OCAT) were greater for older patient age, concurrent ligament reconstruction, tibiofemoral bipolar OCAT, and nonadherence to the prescribed postoperative rehabilitation protocols. When adjusted for patients' age, BMI, and tobacco use status, different surgery types did not demonstrate an increased risk for failure, while concurrent ligament reconstruction and nonadherence did. Patients who experienced functional graft survival after primary OCAT reported significantly greater improvements in PROMIS Physical Function and Mobility (Patient-Reported Outcomes Measurement Information System), International Knee Documentation Committee questionnaire, and Single Assessment Numeric Evaluation scores such that they were significantly higher at final follow-up as compared with patients who required arthroplasty. Patient-reported improvements in pain, function, and mobility exceeded minimal clinically important differences for ≥5 years after primary OCAT. When asked if they were satisfied with primary OCAT surgery, 76.2% of patients were very satisfied or satisfied with their results, while 8.5% were neutral and 15.4% were unsatisfied or very unsatisfied. CONCLUSION With use of HCV osteochondral allografts, midterm (5- to 8-year) functional graft survival rates for patients undergoing primary OCAT in the knee were notably higher than previously reported midterm rates for traditional OCATs. When adjusted for patient characteristics, risk factors for nonsurvival included concurrent ligament reconstruction for knee instability and nonadherence to the prescribed postoperative rehabilitation protocols. Patients who experienced functional graft survival for ≥5 years after primary OCAT reported statistically significant and clinically meaningful improvements in pain, function, and mobility.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用高软骨细胞活力移植物进行膝关节骨软骨异体移植后的中期疗效
背景骨软骨异体移植(OCAT)已成为大面积无症状关节缺损患者的标准治疗方案。据报道,同种异体移植科学和 OCAT 方案的最新进展使膝关节 OCAT 取得了持续稳健的疗效。假设考虑到患者年龄较大、体重指数(BMI)较高、胫股骨双极OCAT以及不遵守术后康复规定等导致存活率较低的风险因素,所有OCAT的中期功能性移植物存活率总和将超过80%。方法根据两个临床相关定义对使用高软骨细胞活力(HCV)骨软骨异体移植物进行初次OCAT后≥5年且有结果数据的患者进行分析:(1)初次治疗失败,即在研究期间的任何时间点对初次OCAT进行翻修或关节成形术;(2)功能性移植物失败,即在研究期间的任何时间点对初次或翻修OCAT后转为关节成形术的记录。研究人员对每种定义的结果进行了分析评估,并分别对年龄组、性别、肥胖状况、吸烟情况、OCAT手术类型、截骨情况、同时接受韧带手术的情况以及术后规范的遵守情况进行了分析。卡普兰-梅耶分析用于评估存活率的差异,Cox比例危险模型用于评估风险因素以及与存活率的多变量关系。结果分析了134名患者的137次初级膝关节OCAT手术,平均随访66个月(59名女性,75名男性;平均年龄37.8岁;平均体重指数28.5)。在所有病例中,使用 HCV 移植物进行膝关节初级 OCAT 的患者中期(5 至 8 年)功能移植物存活率为 82%,胫骨股骨双极 HCV OCAT 为 69%,髌骨股骨双极为 89%,多面单极为 94%,单面单极为 97%。在患者年龄较大、同时进行韧带重建、胫股骨双极 OCAT 以及不遵守规定的术后康复方案的情况下,初次治疗失败率(初次 OCAT 后进行翻修或关节成形术)和 OCAT 非存活率(初次或翻修 OCAT 后进行关节成形术)更高。根据患者的年龄、体重指数和吸烟情况进行调整后,不同手术类型的失败风险并没有增加,而同时进行韧带重建和不遵守规定的风险却增加了。初治OCAT术后功能性移植物存活的患者在PROMIS身体功能和活动度(患者报告结果测量信息系统)、国际膝关节文献委员会问卷调查和单一评估数字评价得分方面的改善幅度明显更大,因此与需要进行关节置换术的患者相比,他们在最终随访时的得分明显更高。初治OCAT术后≥5年,患者报告的疼痛、功能和活动度改善情况超过了最小临床重要差异。结论使用HCV骨软骨异体移植物后,膝关节初级OCAT患者的中期(5至8年)功能移植物存活率明显高于之前报道的传统OCAT中期存活率。根据患者特征进行调整后,不存活的风险因素包括同时进行膝关节不稳的韧带重建和不遵守规定的术后康复方案。初治 OCAT 术后功能性移植物存活≥5 年的患者在疼痛、功能和活动度方面均有显著的统计学意义和临床意义的改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Thank You, Reviewers! Strengthening the Evidence: Addressing Biases in Anterior Cruciate Ligament Reconstruction Studies: Response Strengthening the Evidence: Addressing Biases in Anterior Cruciate Ligament Reconstruction Studies: Letter to the Editor In Gratitude Presidential Address of the American Orthopaedic Society for Sports Medicine
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1